Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The choice of a preferred first-line treatment requires balancing the desire for optimal
disease control with the occurrence of early and late treatment-related effects. To fully
assess this balance, the treatment decision process should ideally take into account the
outcome following a consistent second-line therapy, in particular when tolerated, widely
applicable and highly effective salvage regimens exist, like in Hodgkin lymphoma failing
initial chemotherapy.